9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The expression of human antimicrobial peptide LL-37 in the human nasal mucosa.

      American journal of rhinology
      Adult, Antimicrobial Cationic Peptides, metabolism, Case-Control Studies, Humans, Immunohistochemistry, Male, Middle Aged, Nasal Mucosa, pathology, Nasal Polyps, Reverse Transcriptase Polymerase Chain Reaction, Turbinates, Up-Regulation

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          LL-37, an antimicrobial peptide, has been discovered to be produced by a number of epithelial cells. It is identified as a key element in the innate host defense mechanism. Because little is known about the expression of LL-37 in human sinonasal tract, we conducted this study to investigate the expression of LL-37 in human nasal mucosa. We investigated the expression of LL-37 gene by the reverse transcription polymerase chain reaction (RT-PCR) and localization of LL-37 peptide by immunohistochemistry in the inferior turbinate mucosa of 7 normal subjects and the nasal polyps of 12 patients with chronic paranasal sinusitis. The transcripts of the LL-37 gene were detected in all human nasal tissues analyzed by RT-PCR. There is a significant increase of LL-37 mRNA expression in nasal polyps as compared with the normal nasal mucosa. Using immunohistochemistry, LL-37 peptide was localized in surface epithelial cells and submucosal glands. Our findings suggest that LL-37 is expressed by nasal mucosa and is upregulated during inflammation.

          Related collections

          Author and article information

          Comments

          Comment on this article